(Q36918192)

17 August 2017

1 reference

title

Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer (English)

1 reference

17 August 2017

0 references

1 reference

1 reference

Vona-Davis L

1

1 reference

PubMed ID

17716297

17 August 2017

Howard-McNatt M

series ordinal

2

1 reference

PubMed ID

17716297

17 August 2017

Rose DP

series ordinal

3

1 reference

17 August 2017

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

8

1 reference

17 August 2017

395-408

1 reference

17 August 2017

5

1 reference

The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Breast cancer and obesity: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Central obesity and breast cancer risk: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Review of anthropometric factors and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Weight loss in breast cancer patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Obesity and breast cancer: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Obesity, adipocytokines, and insulin resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Body size and breast cancer prognosis: a critical review of the evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Metabolic syndrome: a clinical and molecular perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

A comparison of the prevalence of the metabolic syndrome using two proposed definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Separate associations between visceral and subcutaneous adipose tissue distribution, insulin and glucose levels in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Mortality from site-specific malignancies in type 2 diabetic patients from Verona

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Risk of endometrial and breast cancer in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Diabetes mellitus and breast cancer: a retrospective population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Metabolic disorders and breast cancer risk (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Selected medical conditions and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Risk factors for breast cancer in Turkish women: a hospital-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Breast cancer risk in young women and history of selected medical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Diabetes mellitus and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Metabolic syndrome as a prognostic factor for breast cancer recurrences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Insulin resistance and breast-cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Serum levels of leptin, insulin, and lipids in relation to breast cancer in china

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Aromatase and breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Estrogen production and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

A prospective study of endogenous estrogens and breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Obese young men have elevated plasma estrogen levels but obese premenopausal women do not

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Sex hormone levels in premenopausal African-American women with upper and lower body fat phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Sex hormone-binding globulin and insulin resistance in African-American women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Serum sex-hormone-binding globulin is related to hepatic and peripheral insulin sensitivity but not to beta-cell function in men and women with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Correlates of circulating androgens in mid-life women: the study of women's health across the nation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Leptin Levels in Type 2 Diabetes: Associations with Measures of Insulin Resistance and Insulin Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Role of leptin in obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Leptin is a growth factor in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin as a biomarker of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Hypoadiponectinemia is an independent risk factor for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Serum adiponectin and leptin levels in Taiwanese breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Plasma adiponectin concentrations and risk of incident breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Proportion of breast cancer cases in the United States explained by well-established risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Association of gain and loss of weight before and after menopause with risk of postmenopausal breast cancer in the Iowa women's health study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Adult weight change and risk of postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Omega-3 fatty acids as cancer chemopreventive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Breast cancer growth prevention by statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Statins can inhibit proliferation of human breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Statin use and breast cancer risk in a large population-based setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Rosiglitazone inhibits endothelial proliferation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

Hypertension and Hormone-Related Neoplasms in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

The nutrition transition: worldwide obesity dynamics and their determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1467-789X.2007.00396.X

10.1111/J.1467-789X.2007.00396.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17716297